< Back to search
Filter
1

Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) Following Stem Cell Transplantation for the Treatment of Intermediate or High Grade B-cell Non-Hodgkin Lymphoma

for
B-Cell Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT05432635

Phase1, Recruiting

A Registry for People With T-cell Lymphoma

for
T-cell Lymphoma, NK-Cell Lymphoma,
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 0+

Code: NCT05978141

Recruiting

Emapalumab Prevention of CAR-T Cell Associated Toxicities

for
Large B-cell Lymphoma, Relapsed Non-Hodgkin Lymphoma,
Location: Boston MA
Sponsor: Marcela V. Maus, M.D.,Ph.D.

Sex: All

Age: 18+

Code: NCT06550141

Phase2, Recruiting

Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Rochester MN, Scottsdale AZ
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT03516617

Phase2, Recruiting

Pirtobrutinib (LOXO-305) and Venetoclax for the Treatment of Patients With CLL or SLL Resistant to Covalent BTKi

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Columbus OH
Sponsor: Kerry Rogers

Sex: All

Age: 18+

Code: NCT06466122

Phase2, Recruiting

Interested in new lymphoma trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies

for
Non Hodgkin Lymphoma (NHL), Mantle Cell Lymphoma (MCL),
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin

Sex: All

Age: 18 - 70+

Code: NCT04186520

Phase1, Phase2, Recruiting

A Phase II Study of the Combination of Pembrolizumab and ATRA Combination Treatment of Relapsed HL and B-NHL

for
Relapsed Hodgkin Lymphoma, Refractory Hodgkin Lymphoma,
Location: Indianapolis IN
Sponsor: Rita Assi

Sex: All

Age: 18+

Code: NCT06484920

Phase2, Recruiting

Acalabrutinib in Combination With Venetoclax for the Treatment of Refractory or Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, The AVENUE-2 Trial

for
Recurrent Chronic Lymphocytic Leukemia,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT04941716

Phase2, Recruiting

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

for
B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma,
Location: Boston MA, Quebec, New York NY, Bethesda MD,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT05006716

Phase1, Phase2, Recruiting

Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas

for
Diffuse Large Cell Lymphoma, Non-Hodgkin Lymphoma,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT05389423

Phase1, Recruiting

A Dose Study of Doxil in a Dose Dense, 14 Day CDOP/Rituximab Regimen for Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma (NHL)> 60 Years or With Compromised Cardiac Status.

for
Diffuse Large B Cell Lymphoma, Lymphoma, Non-Hodgkin
Location: Baltimore MD, Randallstown MD
Sponsor: The Alvin and Lois Lapidus Cancer Institute

Sex: All

Age: 18+

Code: NCT00333008

Phase2, Recruiting

Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Leukemias

for
Leukemia, Lymphocytic, Chronic, B-Cell,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT06364423

Phase1, Phase2, Recruiting

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

for
Clonal Cytopenia of Undetermined Significance,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT03418038

Phase2, Recruiting

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia

for
Recurrent Acute Lymphoblastic Leukemia,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 15+

Code: NCT03136146

Phase2, Recruiting

A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma

for
Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma
Location: Newnan GA, Zion IL, Goodyear AZ, Duarte CA
Sponsor: VIVUS LLC

Sex: All

Age: 18+

Code: NCT06915246

Phase2, Recruiting

Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases

for
Childhood Langerhans Cell Histiocytosis, Fanconi Anemia,
Location: Hershey PA
Sponsor: Milton S. Hershey Medical Center

Sex: All

Age: 0 - 21

Code: NCT00084695

Phase2, Recruiting

Photopheresis in Early-stage Mycosis Fungoides

for
Cutaneous T Cell Lymphoma, Mycosis Fungoides
Location: New York NY
Sponsor: Columbia University

Sex: All

Age: 18+

Code: NCT05680558

Phase2, Recruiting

An Engineered Sirpα Fused to Anti-Pd-L1 And Tgf-β Fusion Protein (HCB301) in Subjects With Selected Advanced Tumors

for
Advanced Solid Tumor, Refractory Hodgkin Lymphoma
Location: Greenville SC
Sponsor: FBD Biologics Limited

Sex: All

Age: 18+

Code: NCT06487624

Phase1, Recruiting

Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma

for
B-ALL, DLBCL, B ALL, Dlbcl-Ci, DLBCL Unclassifiable,
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT04512716

Early_phase1, Recruiting

Epco, Zanu, Ritux for R/R FL or MZL

for
Follicular Lymphoma, Lymphoma, Non-Hodgkin Lymphoma,
Location: Boston MA, New York NY, Columbus OH
Sponsor: Reid Merryman, MD

Sex: All

Age: 18+

Code: NCT06563596

Phase2, Recruiting